Does REBIF Cause Maternal exposure timing unspecified? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Maternal exposure timing unspecified have been filed in association with REBIF. This represents 1.4% of all adverse event reports for REBIF.
25
Reports of Maternal exposure timing unspecified with REBIF
1.4%
of all REBIF reports
0
Deaths
3
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From REBIF?
Of the 25 reports, 3 (12.0%) required hospitalization.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REBIF. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does REBIF Cause?
Multiple sclerosis relapse (158)
Injection site erythema (137)
Influenza like illness (128)
Fatigue (123)
Injection site pain (105)
Headache (96)
Injection site bruising (74)
Pyrexia (74)
Fall (73)
Pneumonia (69)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which REBIF Alternatives Have Lower Maternal exposure timing unspecified Risk?
REBIF vs REBOXETINE
REBIF vs RECLAST
REBIF vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
REBIF vs REGADENOSON
REBIF vs REGORAFENIB